Multiple myeloma-associated amyloidosis is an independent high-risk prognostic factor

Overexpression of CD158 and NKG2A Inhibitory Receptors and Underexpression of NKG2D and NKp46 Activating Receptors on NK Cells in Acute Myeloid Leukemia

Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukemia

Intravesical rhGM-CSF for the treatment of late onset hemorrhagic cystitis after bone marrow transplant

Maternal obesity associated with increase in natural killer T cells and CD8+ regulatory T cells in cord blood units

Clinical relevance of NK, NKT, and dendritic cell dose in patients receiving G-CSF-mobilized peripheral blood allogeneic stem cell transplantation